GARDP in the Financial Times: Antibiotic resistance raises prospect of untreatable gonorrhoea

Since the first treatment for gonorrhoea became widely available in the 1930s, the bacteria has built up resistance to seven types of antibiotics, rendering them all almost completely useless. Only one treatment course remains for the sexually transmitted infection (STI), which can be traced back to the earliest records of human history and generated 82mn cases globally in 2020, according to World Health Organization data. But, in recent years, gonorrhoea “superbugs”, which have developed resistance to even the last-line treatment, have started to emerge. Public health officials fear an entirely untreatable version of gonorrhoea may not be far off, unless antibiotic use is more carefully monitored and the pipeline for future treatments is further developed.

Read the full article in the Financial Times